APO Research
Talk to an analyst

APO RESEARCH · REPORT

Therapeutic Radioisotopes

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Therapeutic Radioisotopes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025199 pages

Choose your research edition.

Industry ResearchTherapeutic Radioisotopes Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Therapeutic Radioisotopes Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Therapeutic Radioisotopes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Therapeutic Radioisotopes Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Therapeutic Radioisotopes Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Therapeutic Radioisotopes market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Therapeutic Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Therapeutic Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Therapeutic Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Therapeutic Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Therapeutic Radioisotopes include Novartis, Bayer, Q BioMed, Mundipharma, Lantheus, Jubilant Radiopharma, International Isotopes, Dongcheng and Curium Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Therapeutic Radioisotopes market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Therapeutic Radioisotopes and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Therapeutic Radioisotopes sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Therapeutic Radioisotopes market size, projected growth trends, production technologies, key applications, and end-use industries.

Therapeutic Radioisotopes Segment by Company

Novartis

Bayer

Q BioMed

Mundipharma

Lantheus

Jubilant Radiopharma

International Isotopes

Dongcheng

Curium Pharmaceuticals

China Isotope & Radiation

Aurobindo Pharma

Therapeutic Radioisotopes Segment by Type

Lutetium-177

Radium-223

Iodine-131

Other

Therapeutic Radioisotopes Segment by Application

Lymphoma

Thyroid

Bone Metastasis

Other

Therapeutic Radioisotopes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Radioisotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Radioisotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Radioisotopes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Therapeutic Radioisotopes market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Therapeutic Radioisotopes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Therapeutic Radioisotopes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Therapeutic Radioisotopes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Therapeutic Radioisotopes Industry Trends Table 2. Therapeutic Radioisotopes Industry Drivers Table 3. Therapeutic Radioisotopes Industry Opportunities and Challenges Table 4. Therapeutic Radioisotopes Industry Restraints Table 5. Global Therapeutic Radioisotopes Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Therapeutic Radioisotopes Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Therapeutic Radioisotopes Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Therapeutic Radioisotopes Sales Market Share by Manufacturers Table 9. Global Therapeutic Radioisotopes Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Therapeutic Radioisotopes Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Therapeutic Radioisotopes Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Therapeutic Radioisotopes Manufacturers, Product Type & Application Table 13. Global Therapeutic Radioisotopes Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Therapeutic Radioisotopes by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Lutetium-177 Table 17. Major Manufacturers of Radium-223 Table 18. Major Manufacturers of Iodine-131 Table 19. Major Manufacturers of Other Table 20. Global Therapeutic Radioisotopes Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Therapeutic Radioisotopes Sales by Type (2021-2026) & (k units) Table 22. Global Therapeutic Radioisotopes Sales by Type (2027-2032) & (k units) Table 23. Global Therapeutic Radioisotopes Sales Market Share by Type (2021-2026) Table 24. Global Therapeutic Radioisotopes Sales Market Share by Type (2027-2032) Table 25. Global Therapeutic Radioisotopes Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Therapeutic Radioisotopes Revenue by Type (2021-2026) & (k units) Table 27. Global Therapeutic Radioisotopes Revenue by Type (2027-2032) & (k units) Table 28. Global Therapeutic Radioisotopes Revenue Market Share by Type (2021-2026) Table 29. Global Therapeutic Radioisotopes Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Lymphoma Table 31. Major Manufacturers of Thyroid Table 32. Major Manufacturers of Bone Metastasis Table 33. Major Manufacturers of Other Table 34. Global Therapeutic Radioisotopes Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Therapeutic Radioisotopes Sales by Application (2021-2026) & (k units) Table 36. Global Therapeutic Radioisotopes Sales by Application (2027-2032) & (k units) Table 37. Global Therapeutic Radioisotopes Sales Market Share by Application (2021-2026) Table 38. Global Therapeutic Radioisotopes Sales Market Share by Application (2027-2032) Table 39. Global Therapeutic Radioisotopes Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Therapeutic Radioisotopes Revenue by Application (2021-2026) & (k units) Table 41. Global Therapeutic Radioisotopes Revenue by Application (2027-2032) & (k units) Table 42. Global Therapeutic Radioisotopes Revenue Market Share by Application (2021-2026) Table 43. Global Therapeutic Radioisotopes Revenue Market Share by Application (2027-2032) Table 44. Global Therapeutic Radioisotopes Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Therapeutic Radioisotopes Sales by Region (2021-2026) & (k units) Table 46. Global Therapeutic Radioisotopes Sales Market Share by Region (2021-2026) Table 47. Global Therapeutic Radioisotopes Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Therapeutic Radioisotopes Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Therapeutic Radioisotopes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Therapeutic Radioisotopes Sales by Country (2021-2026) & (k units) Table 51. North America Therapeutic Radioisotopes Sales by Country (2027-2032) & (k units) Table 52. Europe Therapeutic Radioisotopes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Therapeutic Radioisotopes Sales by Country (2021-2026) & (k units) Table 54. Europe Therapeutic Radioisotopes Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Therapeutic Radioisotopes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Therapeutic Radioisotopes Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Therapeutic Radioisotopes Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Therapeutic Radioisotopes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Therapeutic Radioisotopes Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Therapeutic Radioisotopes Sales by Country (2027-2032) & (k units) Table 61. Global Therapeutic Radioisotopes Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Therapeutic Radioisotopes Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Therapeutic Radioisotopes Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Therapeutic Radioisotopes Revenue Market Share by Region (2021-2026) Table 65. Global Therapeutic Radioisotopes Revenue Market Share by Region (2027-2032) Table 66. Novartis Company Information Table 67. Novartis Business Overview Table 68. Novartis Therapeutic Radioisotopes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Novartis Therapeutic Radioisotopes Product Portfolio Table 70. Novartis Recent Development Table 71. Bayer Company Information Table 72. Bayer Business Overview Table 73. Bayer Therapeutic Radioisotopes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Bayer Therapeutic Radioisotopes Product Portfolio Table 75. Bayer Recent Development Table 76. Q BioMed Company Information Table 77. Q BioMed Business Overview Table 78. Q BioMed Therapeutic Radioisotopes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Q BioMed Therapeutic Radioisotopes Product Portfolio Table 80. Q BioMed Recent Development Table 81. Mundipharma Company Information Table 82. Mundipharma Business Overview Table 83. Mundipharma Therapeutic Radioisotopes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Mundipharma Therapeutic Radioisotopes Product Portfolio Table 85. Mundipharma Recent Development Table 86. Lantheus Company Information Table 87. Lantheus Business Overview Table 88. Lantheus Therapeutic Radioisotopes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Lantheus Therapeutic Radioisotopes Product Portfolio Table 90. Lantheus Recent Development Table 91. Jubilant Radiopharma Company Information Table 92. Jubilant Radiopharma Business Overview Table 93. Jubilant Radiopharma Therapeutic Radioisotopes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Jubilant Radiopharma Therapeutic Radioisotopes Product Portfolio Table 95. Jubilant Radiopharma Recent Development Table 96. International Isotopes Company Information Table 97. International Isotopes Business Overview Table 98. International Isotopes Therapeutic Radioisotopes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. International Isotopes Therapeutic Radioisotopes Product Portfolio Table 100. International Isotopes Recent Development Table 101. Dongcheng Company Information Table 102. Dongcheng Business Overview Table 103. Dongcheng Therapeutic Radioisotopes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Dongcheng Therapeutic Radioisotopes Product Portfolio Table 105. Dongcheng Recent Development Table 106. Curium Pharmaceuticals Company Information Table 107. Curium Pharmaceuticals Business Overview Table 108. Curium Pharmaceuticals Therapeutic Radioisotopes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Curium Pharmaceuticals Therapeutic Radioisotopes Product Portfolio Table 110. Curium Pharmaceuticals Recent Development Table 111. China Isotope & Radiation Company Information Table 112. China Isotope & Radiation Business Overview Table 113. China Isotope & Radiation Therapeutic Radioisotopes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. China Isotope & Radiation Therapeutic Radioisotopes Product Portfolio Table 115. China Isotope & Radiation Recent Development Table 116. Aurobindo Pharma Company Information Table 117. Aurobindo Pharma Business Overview Table 118. Aurobindo Pharma Therapeutic Radioisotopes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Aurobindo Pharma Therapeutic Radioisotopes Product Portfolio Table 120. Aurobindo Pharma Recent Development Table 121. Key Raw Materials Table 122. Raw Materials Key Suppliers Table 123. Therapeutic Radioisotopes Distributors List Table 124. Therapeutic Radioisotopes Customers List Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Therapeutic Radioisotopes Product Image Figure 2. Global Therapeutic Radioisotopes Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Therapeutic Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 4. Global Therapeutic Radioisotopes Sales (2021-2032) & (k units) Figure 5. Global Therapeutic Radioisotopes Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Therapeutic Radioisotopes Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Lutetium-177 Image Figure 9. Radium-223 Image Figure 10. Iodine-131 Image Figure 11. Other Image Figure 12. Global Therapeutic Radioisotopes Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Therapeutic Radioisotopes Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Therapeutic Radioisotopes Sales Market Share by Type (2021-2032) Figure 15. Global Therapeutic Radioisotopes Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Therapeutic Radioisotopes Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Therapeutic Radioisotopes Revenue Market Share by Type (2021-2032) Figure 18. Lymphoma Image Figure 19. Thyroid Image Figure 20. Bone Metastasis Image Figure 21. Other Image Figure 22. Global Therapeutic Radioisotopes Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Therapeutic Radioisotopes Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Therapeutic Radioisotopes Sales Market Share by Application (2021-2032) Figure 25. Global Therapeutic Radioisotopes Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Therapeutic Radioisotopes Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Therapeutic Radioisotopes Revenue Market Share by Application (2021-2032) Figure 28. North America Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Therapeutic Radioisotopes Sales Market Share by Country (2021-2032) Figure 30. U.S. Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Therapeutic Radioisotopes Sales Market Share by Country (2021-2032) Figure 35. Germany Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Therapeutic Radioisotopes Sales Market Share by Country (2021-2032) Figure 42. China Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Therapeutic Radioisotopes Sales Market Share by Country (2021-2032) Figure 50. Brazil Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Therapeutic Radioisotopes Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Therapeutic Radioisotopes Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Therapeutic Radioisotopes Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Figure 61. North America Therapeutic Radioisotopes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Figure 63. Europe Therapeutic Radioisotopes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Therapeutic Radioisotopes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Therapeutic Radioisotopes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Therapeutic Radioisotopes Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Therapeutic Radioisotopes Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Lutetium-177
  • Radium-223
  • Iodine-131
  • Other
Applications
  • Lymphoma
  • Thyroid
  • Bone Metastasis
  • Other
Companies covered
  • Novartis
  • Bayer
  • Q BioMed
  • Mundipharma
  • Lantheus
  • Jubilant Radiopharma
  • International Isotopes
  • Dongcheng
  • Curium Pharmaceuticals
  • China Isotope & Radiation
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Therapeutic Radioisotopes Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Therapeutic Radioisotopes Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Therapeutic Radioisotopes Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Therapeutic Radioisotopes Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Therapeutic Radioisotopes Market Dynamics
  1. 2.1 Therapeutic Radioisotopes Industry Trends
  2. 2.2 Therapeutic Radioisotopes Industry Drivers
  3. 2.3 Therapeutic Radioisotopes Industry Opportunities and Challenges
  4. 2.4 Therapeutic Radioisotopes Industry Restraints
3 Therapeutic Radioisotopes Market by Manufacturers
  1. 3.1 Global Therapeutic Radioisotopes Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Therapeutic Radioisotopes Sales by Manufacturers (2021-2026)
  3. 3.3 Global Therapeutic Radioisotopes Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Therapeutic Radioisotopes Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Therapeutic Radioisotopes Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Therapeutic Radioisotopes Manufacturers, Product Type & Application
  7. 3.7 Global Therapeutic Radioisotopes Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Therapeutic Radioisotopes Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Therapeutic Radioisotopes Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Therapeutic Radioisotopes Tier 1, Tier 2, and Tier 3
4 Therapeutic Radioisotopes Market by Type
  1. 4.1 Therapeutic Radioisotopes Type Introduction
  2. 4.1.1 Lutetium-177
  3. 4.1.2 Radium-223
  4. 4.1.3 Iodine-131
  5. 4.1.4 Other
  6. 4.2 Global Therapeutic Radioisotopes Sales by Type
  7. 4.2.1 Global Therapeutic Radioisotopes Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Therapeutic Radioisotopes Sales by Type (2021-2032)
  9. 4.2.3 Global Therapeutic Radioisotopes Sales Market Share by Type (2021-2032)
  10. 4.3 Global Therapeutic Radioisotopes Revenue by Type
  11. 4.3.1 Global Therapeutic Radioisotopes Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Therapeutic Radioisotopes Revenue by Type (2021-2032)
  13. 4.3.3 Global Therapeutic Radioisotopes Revenue Market Share by Type (2021-2032)
5 Therapeutic Radioisotopes Market by Application
  1. 5.1 Therapeutic Radioisotopes Application Introduction
  2. 5.1.1 Lymphoma
  3. 5.1.2 Thyroid
  4. 5.1.3 Bone Metastasis
  5. 5.1.4 Other
  6. 5.2 Global Therapeutic Radioisotopes Sales by Application
  7. 5.2.1 Global Therapeutic Radioisotopes Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Therapeutic Radioisotopes Sales by Application (2021-2032)
  9. 5.2.3 Global Therapeutic Radioisotopes Sales Market Share by Application (2021-2032)
  10. 5.3 Global Therapeutic Radioisotopes Revenue by Application
  11. 5.3.1 Global Therapeutic Radioisotopes Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Therapeutic Radioisotopes Revenue by Application (2021-2032)
  13. 5.3.3 Global Therapeutic Radioisotopes Revenue Market Share by Application (2021-2032)
6 Global Therapeutic Radioisotopes Sales by Region
  1. 6.1 Global Therapeutic Radioisotopes Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Therapeutic Radioisotopes Sales by Region (2021-2032)
  3. 6.2.1 Global Therapeutic Radioisotopes Sales by Region (2021-2026)
  4. 6.2.2 Global Therapeutic Radioisotopes Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Therapeutic Radioisotopes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Therapeutic Radioisotopes Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Therapeutic Radioisotopes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Therapeutic Radioisotopes Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Therapeutic Radioisotopes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Therapeutic Radioisotopes Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Therapeutic Radioisotopes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Therapeutic Radioisotopes Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Therapeutic Radioisotopes Revenue by Region
  1. 7.1 Global Therapeutic Radioisotopes Revenue by Region
  2. 7.1.1 Global Therapeutic Radioisotopes Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Therapeutic Radioisotopes Revenue by Region (2021-2026)
  4. 7.1.3 Global Therapeutic Radioisotopes Revenue by Region (2027-2032)
  5. 7.1.4 Global Therapeutic Radioisotopes Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Therapeutic Radioisotopes Revenue (2021-2032)
  8. 7.2.2 North America Therapeutic Radioisotopes Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Therapeutic Radioisotopes Revenue (2021-2032)
  11. 7.3.2 Europe Therapeutic Radioisotopes Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Therapeutic Radioisotopes Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Therapeutic Radioisotopes Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Therapeutic Radioisotopes Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Therapeutic Radioisotopes Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Therapeutic Radioisotopes Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Therapeutic Radioisotopes Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 Q BioMed
  14. 8.3.1 Q BioMed Company Information
  15. 8.3.2 Q BioMed Business Overview
  16. 8.3.3 Q BioMed Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Q BioMed Therapeutic Radioisotopes Product Portfolio
  18. 8.3.5 Q BioMed Recent Developments
  19. 8.4 Mundipharma
  20. 8.4.1 Mundipharma Company Information
  21. 8.4.2 Mundipharma Business Overview
  22. 8.4.3 Mundipharma Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mundipharma Therapeutic Radioisotopes Product Portfolio
  24. 8.4.5 Mundipharma Recent Developments
  25. 8.5 Lantheus
  26. 8.5.1 Lantheus Company Information
  27. 8.5.2 Lantheus Business Overview
  28. 8.5.3 Lantheus Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lantheus Therapeutic Radioisotopes Product Portfolio
  30. 8.5.5 Lantheus Recent Developments
  31. 8.6 Jubilant Radiopharma
  32. 8.6.1 Jubilant Radiopharma Company Information
  33. 8.6.2 Jubilant Radiopharma Business Overview
  34. 8.6.3 Jubilant Radiopharma Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jubilant Radiopharma Therapeutic Radioisotopes Product Portfolio
  36. 8.6.5 Jubilant Radiopharma Recent Developments
  37. 8.7 International Isotopes
  38. 8.7.1 International Isotopes Company Information
  39. 8.7.2 International Isotopes Business Overview
  40. 8.7.3 International Isotopes Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 International Isotopes Therapeutic Radioisotopes Product Portfolio
  42. 8.7.5 International Isotopes Recent Developments
  43. 8.8 Dongcheng
  44. 8.8.1 Dongcheng Company Information
  45. 8.8.2 Dongcheng Business Overview
  46. 8.8.3 Dongcheng Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Dongcheng Therapeutic Radioisotopes Product Portfolio
  48. 8.8.5 Dongcheng Recent Developments
  49. 8.9 Curium Pharmaceuticals
  50. 8.9.1 Curium Pharmaceuticals Company Information
  51. 8.9.2 Curium Pharmaceuticals Business Overview
  52. 8.9.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Curium Pharmaceuticals Therapeutic Radioisotopes Product Portfolio
  54. 8.9.5 Curium Pharmaceuticals Recent Developments
  55. 8.10 China Isotope & Radiation
  56. 8.10.1 China Isotope & Radiation Company Information
  57. 8.10.2 China Isotope & Radiation Business Overview
  58. 8.10.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 China Isotope & Radiation Therapeutic Radioisotopes Product Portfolio
  60. 8.10.5 China Isotope & Radiation Recent Developments
  61. 8.11 Aurobindo Pharma
  62. 8.11.1 Aurobindo Pharma Company Information
  63. 8.11.2 Aurobindo Pharma Business Overview
  64. 8.11.3 Aurobindo Pharma Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Aurobindo Pharma Therapeutic Radioisotopes Product Portfolio
  66. 8.11.5 Aurobindo Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Therapeutic Radioisotopes Value Chain Analysis
  2. 9.1.1 Therapeutic Radioisotopes Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Therapeutic Radioisotopes Production Mode & Process
  6. 9.2 Therapeutic Radioisotopes Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Therapeutic Radioisotopes Distributors
  9. 9.2.3 Therapeutic Radioisotopes Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst